Global Tissue Diagnostics Market, By Product (Consumables, Instruments), By Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), By Application (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Other Diseases), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027
- Published Date: July 2021
- Report ID: BWC21404
- Available Format: PDF
- Page: 143
Report Overview
The term "tissue diagnostics" relates to the diagnosis, monitoring, and management of cancer at various stages. It is one of the most extensively utilized methods for cancer diagnosis. This process emphasizes examining the tumor's current situation as well as the reason for its development throughout treatment.
Global Tissue Diagnostics Market- Industry Trends & Forecast Report 2027
The global tissue diagnostics market was worth USD 4.9 billion in 2020 and is further projected to reach USD 8.1 billion by the year 2027, growing at a CAGR of 7.5% in the forecast period (2021-2027). The rising incidences of cancer, as well as the increased usage of tissue diagnostics for tumor diagnosis, are factors driving the growth of the tissue diagnostics market. Also, improved reimbursement policies, as well as technology improvements, are expected to drive market growth throughout the projection period.
Source: BlueWeave Consulting
Global Tissue Diagnostics Market- Overview
The term "tissue diagnostics" relates to the diagnosis, monitoring, and management of cancer at various stages. It is one of the most extensively utilized methods for cancer diagnosis. This process emphasizes examining the tumor's current situation as well as the reason for its development throughout treatment. Pathologists often have a hard time detecting, visualizing, and monitoring the disease. However, tissue diagnostics offer better results and conclusions for the treatment of cancer. Thus, tissue diagnostics remains a standard method for cancer diagnosis because it captures the biological setting of malignancies.
Global Tissue Diagnostics Market Forecast and Trends
Growth Drivers
Increasing Prevalence of Cancer
The prevalence of cancer is getting more and more common these days. Cancer treatment, on the other hand, is improving as the medical sector advances. Even with the slightest symptoms, people are flocking to hospitals and diagnostic facilities to dispel whatever doubts they may have about cancer. As a result, the market demand for tissue diagnostics is flourishing significantly. Among all the cancer types, the rate of breast cancer is increasing at a very high rate among women. Therefore, women are becoming more aware, which could be another factor for the growth of the market in the forecast period.
Innovations in Tissue Diagnostic Market
The constant research and development in the field of tissue diagnostic have offered several benefits for the growth of the tissue diagnostic market. One of the leading innovations is the development of automated tissue diagnostics and digital pathology. Automated tissue diagnostic allows enhanced assessment and diagnosis process which increases the accuracy. It does away with the requirement for a large number of pathologists to assist during the operation. Digital pathology, on the other hand, makes use of virtual microscopy and other computer-based technology. These factors are contributing significantly to the market growth of the tissue diagnostics market.
Restraints
High Cost of Tissue Diagnostics
The use of tissue diagnostics technology for the treatment of various types of cancer places a strain on hospital budgets. Investing in the deployment of such technology without a guarantee of fair returns appears to be a major risk that many healthcare facilities are hesitant to incur. Furthermore, as the diagnostic centers for cancers are very limited in numbers in the emerging economies, the demand for tissue diagnostics is still not progressing despite the increasing prevalence of cancer in the population, which in turn is stifling the market growth.
Impact of Covid-19 on Global Tissue Diagnostics Market
According to predictions, the global tissue diagnostics industry was set to thrive in the aftermath of the Covid-19-induced pandemic. However, the market is currently under a lot of strain as healthcare facilities prioritize testing and treatment in the Covid-19-infected patients. As a result, diagnostic processes were slightly hampered because people with relevant symptoms were hesitant to visit hospitals. Furthermore, in order to combat the virus, all research and development efforts had shifted to finding a cure. As a result, no further advancements were made in this field. However, in the post-Covid-19 world, the market is predicted to boom as all diagnostic and treatment processes are expected to rapidly escalate.
Global Tissue Diagnostics Market - By Type
Based on type, the global tissue diagnostics market is segmented into consumables and instruments. Among these, the consumables segment dominates the market. The advantages provided by this segment, such as its high consumption demand in cancer treatment, high cost, and ease of use, drive the market expansion of consumables. It also has several sub-segments, i.e., antibodies, kits, reagents, and probes. The demand for consumables is projected to gain significant traction in the forecast period due to the expanding reagents rental agreements.
Global Tissue Diagnostics Market - By Technology
Based on technology, the global tissue diagnostics market is categorized into Immunohistochemistry (IHC), In Situ Hybridization (ISH), digital pathology and workflow management, and special staining. The application of Immunohistochemistry (IHC) is very wide in the diagnosis and monitoring of various types of cancers. Thus, this segment captures the largest share in the global tissue diagnostic market. This is because IHC focuses on different variations of the tumors which often go undetected under conventional enzyme staining techniques. Therefore, they are largely preferred by hospitals, research laboratories, etc., thereby propelling its market growth.
Global Tissue Diagnostics Market - By Application
Based on application, the global tissue diagnostics market is divided into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer (NSCLC), and other diseases. The breast cancer segment accounted for the largest market share in the year 2020, owing to rapidly increasing incidences of breast cancer in women around the globe. According to the World Cancer Research Fund, with approximately 1.7 million new cases reported in 2012, breast cancer is the most frequent disease in women worldwide, accounting for roughly 25% of all malignancies in women. The global prevalence rate varies greatly, ranging from 27 per 100,000 in Middle Africa and Eastern Asia to 92 per 100,000 in Northern America. Heredity is one of the major causes of the growth of breast cancer. The demand for tissue diagnostics in this segment is growing as a result of breast cancer research and development.
Global Tissue Diagnostics Market - Regional Insights
Geographically, the global tissue diagnostics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among these, North America held the largest market share, followed by Europe. These regions are flourishing with high demand for tissue diagnostics due to developed healthcare infrastructure, along with the adoption of advanced technology and easy accessibility of medical services. Furthermore, improved reimbursement policies, as well as growing awareness regarding cancer and its treatment, are also triggering the growth of tissue diagnostics worldwide.
Competitive Landscape
The leading market players in the global tissue diagnostics market are BioGenex Laboratorie, F. Hoffmann-La Roche Ltd, Cancer Genetics, Inc., Genomic Health, Inc., Merck KGaA, Becton, Dickinson And Company, Amos Scientific Pty Ltd, Bio Sb, Sakura Finetek Japan, Slee Medical GMBH, Cellpath Ltd, Hologic, Inc., Medite GMBH, Jinhua Yidi Medical Appliance Co. Ltd, Histo-Line Laboratoriesm and other prominent players. The companies are focused on expanding their product portfolio to stay ahead in the competition as well as establish their brand all around the globe.
Recent Developments
l In May 2021, Discovery Life Sciences, a global biospecimen, and biomarker specialists company announced to have acquired Targos Molecular Pathology GmbH, a Germany-based molecular pathology laboratory. This acquisition is aimed towards expanding the services of Discovery Life Sciences, making it a global provider for biomarker development, clinical trial support, and in-market clinical pathology.
l In May 2021, Roche Diagnostics, a sub-division of the Hoffmann-La Roche Limited announced its partnership with Canadian Blood Services, a Canadian-based non-profit organization to expand the study immune response to SARS-CoV-2.
Scope of the Report
| Attributes | Details |
| Years Considered | Historical data – 2017-2020 |
| Base Year – 2020 | |
| Forecast – 2021 – 2027 | |
| Facts Covered | Revenue in USD Million |
| Market Coverage | North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa |
| Product Service/Segmentation | By Product, By Technology, By Application, By Region |
| Key Players | Abbott Laboratories, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, BioGenex Laboratories, F. Hoffmann-La Roche Ltd, Cancer Genetics, Inc., Genomic Health, Inc., Merck KGaA, Becton, Dickinson And Company, Amos Scientific PTY Ltd, Bio Sb, Sakura Finetek Japan, Slee Medical GMBH, Cellpath Ltd, Hologic, Inc., Medite GMBH, Jinhua Yidi Medical Appliance Co. Ltd, Histo-Line Laboratories, and other prominent players. |
By Product
1. Consumables
- Antibodies
- Kits
- Reagents
- Probes
2. Instruments
- Slide-Staining Systems
- Scanners
- Tissue-Processing Systems
- Other Instruments
By Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology And Workflow Management
- Special Staining
By Application
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
By Region
- North America
- Europe
- Asia-Pacific (APAC)
- Latin America (LATAM)
- Middle-East & Africa (MEA)
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary and Secondary Sources
2.2. Quantitative Research
2.2.1. Primary and Secondary Sources
2.3. Breakdown of Primary Research Respondents
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Industry Participants
2.5. Key Questionnaire asked during Primary Interviews
2.6. Key Primary Responses
2.7. Market Size Estimation
2.8. Assumption for the Study
2.9. Market Breakdown & Data Triangulation
3. Executive Summary
4. Global Tissue Diagnostics Market – Industry Insights
4.1. DROC Analysis
4.1.1. Growth Drivers
4.1.2. Restraints
4.1.3. Opportunity
4.1.4. Challenges
4.2. Recent Developments / Technical Landscape
4.3. Regulatory Framework
4.4. Porter’s Five Forces Analysis
4.5. Value Chain Analysis
4.6. Strategic Outlook
5. Global Tissue Diagnostics Market Overview
5.1. Market Estimates & Forecast by Value, 2017-2027
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1.1. Consumables
5.2.1.1.1. Antibodies
5.2.1.1.2. Kits
5.2.1.1.3. Reagents
5.2.1.1.4. Probes
5.2.1.2. Instruments
5.2.1.2.1. Slide-Staining Systems
5.2.1.2.2. Scanners
5.2.1.2.3. Tissue-Processing Systems
5.2.1.2.4. Other Instruments
5.2.2. By Technology
5.2.2.1. Immunohistochemistry (IHC)
5.2.2.2. In Situ Hybridization (ISH)
5.2.2.3. Digital Pathology And Workflow Management
5.2.2.4. Special Staining
5.2.3. By Application
5.2.3.1. Breast Cancer
5.2.3.2. Gastric Cancer
5.2.3.3. Lymphoma
5.2.3.4. Prostate Cancer
5.2.3.5. Non-Small Cell Lung Cancer (NSCLC)
5.2.3.6. Other Diseases
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia-Pacific (APAC)
5.2.4.4. Latin America (LATAM)
5.2.4.5. Middle-East & Africa (MEA)
6. North America Tissue Diagnostics Market Overview
6.1. Market Size and Forecast
6.1.1. By Value (USD Million), 2017-2027
6.2. Market Share and Forecast
6.2.1. By Product
6.2.2. By Technology
6.2.3. By Application
6.2.4. By Country
6.2.4.1. U.S.
6.2.4.2. Canada
7. Europe Tissue Diagnostics Market Overview
7.1. Market Size and Forecast
7.1.1. By Value (USD Million), 2017-2027
7.2. Market Share and Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By Application
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. U.K.
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Spain
7.2.4.6. Russia
7.2.4.7. Netherlands
7.2.4.8. Rest of Europe
8. APAC Tissue Diagnostics Market Overview
8.1. Market Size and Forecast
8.1.1. By Value (USD Million), 2017-2027
8.2. Market Share and Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By Application
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. South Korea
8.2.4.5. Rest of APAC
9. LATAM Tissue Diagnostics Market Overview
9.1. Market Size and Forecast
9.1.1. By Value (USD Million), 2017-2027
9.2. Market Share and Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Diagnostic Method
9.2.4. By Application
9.2.5. By Country
9.2.5.1. Mexico
9.2.5.2. Brazil
9.2.5.3. Rest of LATAM
10.MEA Tissue Diagnostics Market Overview
10.1. Market Size and Forecast
10.1.1. By Value (USD Million), 2017-2027
10.2. Market Share and Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Application
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Turkey
10.2.4.5. Rest of Europe
11.Competitive Landscape
11.1.1. List of Key Producers and Their Offerings
11.1.2. Market Share / Ranking Analysis (2020)
11.1.3. Competitive Benchmarking, By Operating Parameters
12.COVID-19 Impact
12.1. Future Impact
12.2. Key Developments during COVID-19
12.3. Impact on Market
12.3.1. Different Scenario
12.3.2. Impact on Companies
12.4. Regional Impact
13.Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
13.1. Abbott Laboratories
13.2. Danaher Corporation
13.3. Agilent Technologies, Inc.
13.4. Thermo Fisher Scientific
13.5. BioGenex Laboratories
13.6. F. Hoffmann-La Roche Ltd
13.7. Cancer Genetics, Inc.
13.8. Genomic Health, Inc.
13.9. Merck KGaA
13.10. Becton, Dickinson And Company
13.11. Amos Scientific Pty Ltd
13.12. Bio Sb
13.13. Sakura Finetek Japan
13.14. Slee Medical GMBH
13.15. Cellpath Ltd
13.16. Hologic, Inc.
13.17. Medite GMBH
13.18. Jinhua Yidi Medical Appliance Co. Ltd
13.19. Histo-Line Laboratories
13.20. Other Prominent Players
14.Key Strategic Recommendations
* Financial information of non-listed Companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.
List of Figures
Fig: Global Tissue Diagnostics Segmentation
Fig: Global Tissue Diagnostics Market Value Chain Analysis,
Fig: Company Market Share Analysis, 2020
Fig: Global Tissue Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Global Tissue Diagnostics Market Share (%), By Product, By Value, 2017-2027
Fig: Global Tissue Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Global Tissue Diagnostics Market Share (%), By Application By Value, 2017-2027
Fig: Global Tissue Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: North America Tissue Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: North America Tissue Diagnostics Market Share (%), By Product, By Value, 2017-2027
Fig: North America Tissue Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: North America Tissue Diagnostics Market Share (%), By Application By Value, 2017-2027
Fig: North America Tissue Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Europe Tissue Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Europe Tissue Diagnostics Market Share (%), By Product, By Value, 2017-2027
Fig: Europe Tissue Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Europe Tissue Diagnostics Market Share (%), By Application By Value, 2017-2027
Fig: Europe Tissue Diagnostics Market Share (%), by End Users, By Value, 2017-2027
Fig: Europe Tissue Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Asia-Pacific Tissue Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Asia-Pacific Tissue Diagnostics Market Share (%), By Product, By Value, 2017-2027
Fig: Asia-Pacific Tissue Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Asia-Pacific Tissue Diagnostics Market Share (%), By Application By Value, 2017-2027
Fig: Asia-Pacific Tissue Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Latin America Tissue Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Latin America Tissue Diagnostics Market Share (%), By Product, By Value, 2017-2027
Fig: Latin America Tissue Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Latin America Tissue Diagnostics Market Share (%), By Application By Value, 2017-2027
Fig: Latin America Tissue Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Middle East & Africa Tissue Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Middle East & Africa Tissue Diagnostics Market Share (%), By Product, By Value, 2017-2027
Fig: Middle East & Africa Tissue Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Middle East & Africa Tissue Diagnostics Market Share (%), By Application By Value, 2017-2027
Fig: Middle East & Africa Tissue Diagnostics Market Share (%), By Region, By Value, 2017-2027
List of Tables
Table: North America Tissue Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027
Table: North America Tissue Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: North America Tissue Diagnostics Market Size, By Application By Value (USD Million), 2017-2027
Table: Europe Tissue Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027
Table: Europe Tissue Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: Europe Tissue Diagnostics Market Size, By Application By Value (USD Million), 2017-2027
Table: the Asia-Pacific Tissue Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Tissue Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Tissue Diagnostics Market Size, By Application By Value (USD Million), 2017-2027
Table: Latin America Tissue Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027
Table: Latin America Tissue Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: Latin America Tissue Diagnostics Market Size, By Application By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Tissue Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Tissue Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Tissue Diagnostics Market Size, By Application By Value (USD Million), 2017-2027
Table: Abbott Laboratories Financial Analysis
Table: Abbott Laboratories Business Overview
Table: Danaher Corporation Financial Analysis
Table: Danaher Corporation Business Overview
Table: Agilent Technologies, Inc. Financial Analysis
Table: Agilent Technologies, Inc. Business Overview
Table: Thermo Fisher Scientific Financial Analysis
Table: Thermo Fisher Scientific Business Overview
Table: BioGenex Laboratories Financial Analysis
Table: BioGenex Laboratories Business Overview
Table: F. Hoffmann-La Roche Ltd Financial Analysis
Table: F. Hoffmann-La Roche Ltd Business Overview
Table: Cancer Genetics, Inc. Financial Analysis
Table: Cancer Genetics, Inc. Business Overview
Table: Genomic Health, Inc. Financial Analysis
Table: Genomic Health, Inc. Business Overview
Table: Merck KGaA Financial Analysis
Table: Merck KGaA Business Overview
Table: Becton, Dickinson And Company Financial Analysis
Table: Becton, Dickinson And Company Business Overview
Table: Amos Scientific PTY Ltd Financial Analysis
Table: Amos Scientific PTY Ltd Financial Analysis
Table: Sakura Finetek Japan Glass Financial Analysis
Table: Sakura Finetek Japan Glass Business Overview
Market Segmentation
By Product
1. Consumables
- Antibodies
- Kits
- Reagents
- Probes
2. Instruments
- Slide-Staining Systems
- Scanners
- Tissue-Processing Systems
- Other Instruments
By Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology And Workflow Management
- Special Staining
By Application
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
By Region
- North America
- Europe
- Asia-Pacific (APAC)
- Latin America (LATAM)
- Middle-East & Africa (MEA)
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.